JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
UPDATE: JPMorgan Upgrades Neurocrine Bio. (NBIX) to Overweight
-
-
-
-
-
-
-
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2019 Net Product Sales Results and 2020 Program Milestones
-
-
-
-
-
-
-
Neurocrine Bio. (NBIX) PT Lowered to $97 at JPMorgan
-
-
-
-
-
-
-
Pre-Open Stock Movers 05/31: (CPXX) (CLF) (SODA) Higher; (OSIR) Lower (more...)
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) to Offer $225M in Common Stock
-
-
-
-
-
-
-
Pre-Open Movers: MoneyGram (MGI) Sinks On Investment Losses, Manatron (MANA), Lifecore Biomedical (LCBM) Up on Buyouts
208,977 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All